journal article·2018-09Open access

Self‐Assembly of Immune Signals Improves Codelivery to Antigen Presenting Cells and Accelerates Signal Internalization, Processing Kinetics, and Immune Activation

Michelle L. Bookstaver, Krystina L. Hess, Christopher M. Jewell

Small· Volume 14· Issue 38

Abstract

Abstract Vaccines and immunotherapies that elicit specific types of immune responses offer transformative potential to tackle disease. The mechanisms governing the processing of immune signals—events that determine the type of response generated—are incredibly complex. Understanding these processes would inform more rational vaccine design by linking carrier properties, processing mechanisms, and relevant timescales to specific impacts on immune response. This goal is pursued using nanostructured materials—termed immune polyelectrolyte multilayers—built entirely from antigens and stimulatory toll‐like receptors agonists (TLRas). This simplicity allows isolation and quantification of the rates and mechanisms of intracellular signal processing, and the link to activation of distinct immune pathways. Each vaccine component is internalized in a colocalized manner through energy‐dependent caveolae‐mediated endocytosis. This process results in trafficking through endosome/lysosome pathways and stimulation of TLRs expressed on endosomes/lysosomes. The maximum rates for these events occur within 4 h, but are detectable in minutes, ultimately driving downstream proimmune functions. Interestingly, these uptake, processing, and activation kinetics are significantly faster for TLRas in particulate form compared with free TLRa. Our findings provide insight into specific mechanisms by which particulate vaccines enhance initiation of immune response, and highlight quantitative strategies to assess other carrier technologies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Monoclonal and Polyclonal Antibodies Research · T-cell and B-cell Immunology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Fischell Department of Bioengineering University of Maryland 8278 Paint Branch Drive College Park MD 20742 USA

United States Department of Veterans Affairs VA Maryland Health Care System 10 North Greene Street Baltimore MD 21201 USA

Robert E. Fischell Institute for Biomedical Devices 8278 Paint Branch Drive College Park MD 20742 USA

Department of Microbiology and Immunology University of Maryland School of Medicine 685 West Baltimore Street Baltimore MD 21201 USA

Marlene and Stewart Greenebaum Cancer Center 22 South Greene Street Baltimore MD 21201 USA

Funding

U.S. Department of Veterans Affairs · Damon Runyon Cancer Research Foundation · National Science Foundation · Alliance for Cancer Gene Therapy · National Institutes of Health · Melanoma Research Alliance

References (54)

Show source-provided references
1. 10.3109/08830185.2015.108217710.3109/08830185.2015.1082177 ↗
2. 10.1021/acsbiomaterials.5b0037510.1021/acsbiomaterials.5b00375 ↗
3. 10.1021/acsami.6b0627510.1021/acsami.6b06275 ↗
4. 10.1016/j.vaccine.2015.02.07310.1016/j.vaccine.2015.02.073 ↗
5. 10.1126/scitranslmed.300998010.1126/scitranslmed.3009980 ↗
6. 10.1016/j.vaccine.2010.08.00210.1016/j.vaccine.2010.08.002 ↗
7. 10.1002/0471142735.im1412s10910.1002/0471142735.im1412s109 ↗
8. 10.1038/nri344610.1038/nri3446 ↗
9. 10.1016/j.cyto.2015.02.02510.1016/j.cyto.2015.02.025 ↗
10. Abbas A. K. · 2014
11. 10.1111/j.1600-065X.2010.00978.x10.1111/j.1600-065X.2010.00978.x ↗
12. 10.1038/nm.340910.1038/nm.3409 ↗
13. 10.1586/14760584.2014.86371510.1586/14760584.2014.863715 ↗
14. 10.1038/icb.2016.1810.1038/icb.2016.18 ↗
15. 10.4049/jimmunol.180.3.153510.4049/jimmunol.180.3.1535 ↗
16. 10.4049/jimmunol.090097410.4049/jimmunol.0900974 ↗
17. 10.1128/JVI.79.5.2910-2919.200510.1128/JVI.79.5.2910-2919.2005 ↗
18. 10.1016/j.it.2017.10.00210.1016/j.it.2017.10.002 ↗
19. 10.1038/nmat235710.1038/nmat2357 ↗
20. 10.1038/nature0973710.1038/nature09737 ↗
21. 10.1021/acsnano.6b0400110.1021/acsnano.6b04001 ↗
22. 10.1016/j.biomaterials.2016.11.05210.1016/j.biomaterials.2016.11.052 ↗
23. 10.1038/s41563-018-0077-610.1038/s41563-018-0077-6 ↗
24. 10.1073/pnas.080489710610.1073/pnas.0804897106 ↗
25. 10.1016/j.biomaterials.2013.09.05010.1016/j.biomaterials.2013.09.050 ↗
26. 10.1021/ja210890510.1021/ja2108905 ↗
27. 10.1016/j.actbio.2015.12.02610.1016/j.actbio.2015.12.026 ↗
28. 10.1002/jbm.a.3597010.1002/jbm.a.35970 ↗
29. 10.1016/j.actbio.2017.12.04010.1016/j.actbio.2017.12.040 ↗
30. 10.1016/j.addr.2008.02.01010.1016/j.addr.2008.02.010 ↗
31. 10.1021/ja106288c10.1021/ja106288c ↗
32. 10.1021/bm050304j10.1021/bm050304j ↗
33. 10.1002/ange.20090376910.1002/ange.200903769 ↗
34. 10.1002/anie.20120004810.1002/anie.201200048 ↗
35. 10.1039/c2cs15296g10.1039/c2cs15296g ↗
36. 10.1021/nn205099c10.1021/nn205099c ↗
37. 10.1021/cm402126n10.1021/cm402126n ↗
38. 10.1038/nmat355010.1038/nmat3550 ↗
39. 10.1016/j.jconrel.2014.07.04310.1016/j.jconrel.2014.07.043 ↗
40. 10.1073/pnas.132382911110.1073/pnas.1323829111 ↗
41. 10.1021/acsbiomaterials.6b0041410.1021/acsbiomaterials.6b00414 ↗
42. 10.1021/acsnano.5b0215310.1021/acsnano.5b02153 ↗
43. 10.1038/nmat296010.1038/nmat2960 ↗
44. 10.1002/eji.20114236110.1002/eji.201142361 ↗
45. 10.1021/nl203021310.1021/nl2030213 ↗
46. 10.1007/s00018-005-5109-010.1007/s00018-005-5109-0 ↗
47. 10.1016/j.bbamem.2010.09.00910.1016/j.bbamem.2010.09.009 ↗
48. 10.1021/nn405726910.1021/nn4057269 ↗
49. 10.1007/s00418-018-1678-510.1007/s00418-018-1678-5 ↗
50. 10.1042/bj2003125310.1042/bj20031253 ↗
51. 10.2147/IJN.S11241510.2147/IJN.S112415 ↗
52. 10.1126/science.108010610.1126/science.1080106 ↗
53. 10.4049/jimmunol.171.6.315410.4049/jimmunol.171.6.3154 ↗
54. 10.4049/jimmunol.164.11.599810.4049/jimmunol.164.11.5998 ↗